Haemonetics Corp
NYSE:HAE

Watchlist Manager
Haemonetics Corp Logo
Haemonetics Corp
NYSE:HAE
Watchlist
Price: 91.7 USD -0.09% Market Closed
Market Cap: 4.7B USD
Have any thoughts about
Haemonetics Corp?
Write Note

Haemonetics Corp
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Haemonetics Corp
Long-Term Debt Peer Comparison

Comparables:
XRAY
ICUI
ALGN
LNTH
MMSI

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Haemonetics Corp
NYSE:HAE
Long-Term Debt
$1.2B
CAGR 3-Years
20%
CAGR 5-Years
31%
CAGR 10-Years
11%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Long-Term Debt
$1.8B
CAGR 3-Years
-2%
CAGR 5-Years
5%
CAGR 10-Years
4%
ICU Medical Inc
NASDAQ:ICUI
Long-Term Debt
$1.6B
CAGR 3-Years
778%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Align Technology Inc
NASDAQ:ALGN
Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Lantheus Holdings Inc
NASDAQ:LNTH
Long-Term Debt
$613k
CAGR 3-Years
-85%
CAGR 5-Years
-68%
CAGR 10-Years
-48%
Merit Medical Systems Inc
NASDAQ:MMSI
Long-Term Debt
$750.5m
CAGR 3-Years
40%
CAGR 5-Years
12%
CAGR 10-Years
13%

See Also

What is Haemonetics Corp's Long-Term Debt?
Long-Term Debt
1.2B USD

Based on the financial report for Sep 28, 2024, Haemonetics Corp's Long-Term Debt amounts to 1.2B USD.

What is Haemonetics Corp's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
11%

Over the last year, the Long-Term Debt growth was 63%. The average annual Long-Term Debt growth rates for Haemonetics Corp have been 20% over the past three years , 31% over the past five years , and 11% over the past ten years .

Back to Top